drug

mevonlerbart

1 story · latest Jun 30, 2026

Status: Investigational
Code: REGN1909
Trials: 1 registered trial in coverage

Relationships

Developed by Regeneron Pharmaceuticals

Timeline

Regeneron registers Phase 3 cat allergy trial and Phase 1/2 glaucoma antibody study

Jun 30Weekly roundup, 2 itemsfreneslerbart mevonlerbart

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.